Senti Biosciences (SNTI) Other Accumulated Expenses (2021 - 2025)
Senti Biosciences' quarterly Other Accumulated Expenses came in at $73000.0 in Q4 2025, down 83.14% year-on-year from $433000.0 in Q4 2024, and up 17.74% quarter-over-quarter from $62000.0 in Q3 2025.
Senti Biosciences has reported Other Accumulated Expenses for 5 years, with the latest figure at $73000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Accumulated Expenses fell 83.14% year-over-year to $73000.0; the trailing twelve-month figure through Dec 2025 stood at $73000.0 (down 83.14% YoY), and the FY2025 full-year result was $73000.0, down 83.14% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $73000.0, up from $62000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $433000.0 in Q4 2024, with the low at $3000.0 in Q1 2024.
- Average Other Accumulated Expenses over 5 years is $93250.0, with a median of $53000.0 recorded in 2023.
- Year-over-year, Other Accumulated Expenses tumbled 94.34% in 2024 and soared 13933.33% in 2025.
- Tracing SNTI's Other Accumulated Expenses over 5 years: stood at $111000.0 in 2021, then tumbled by 73.87% to $29000.0 in 2022, then sank by 68.97% to $9000.0 in 2023, then soared by 4711.11% to $433000.0 in 2024, then slumped by 83.14% to $73000.0 in 2025.
- The last three Other Accumulated Expenses figures came in at $73000.0 (Q4 2025), $62000.0 (Q3 2025), and $53000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 73,000.00 |
| Sep 30, 2025 | 62,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 421,000.00 |
| Dec 31, 2024 | 433,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 76,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 32,000.00 |
| Mar 31, 2023 | 53,000.00 |
| Dec 31, 2022 | 29,000.00 |
| Sep 30, 2022 | 54,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Dec 31, 2021 | 111,000.00 |